1. Home
  2. EXAS vs HII Comparison

EXAS vs HII Comparison

Compare EXAS & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • HII
  • Stock Information
  • Founded
  • EXAS 1995
  • HII 1886
  • Country
  • EXAS United States
  • HII United States
  • Employees
  • EXAS N/A
  • HII N/A
  • Industry
  • EXAS Medical Specialities
  • HII Marine Transportation
  • Sector
  • EXAS Health Care
  • HII Industrials
  • Exchange
  • EXAS Nasdaq
  • HII Nasdaq
  • Market Cap
  • EXAS 10.7B
  • HII 9.1B
  • IPO Year
  • EXAS N/A
  • HII N/A
  • Fundamental
  • Price
  • EXAS $56.13
  • HII $222.91
  • Analyst Decision
  • EXAS Strong Buy
  • HII Hold
  • Analyst Count
  • EXAS 20
  • HII 9
  • Target Price
  • EXAS $70.68
  • HII $229.50
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • HII 476.4K
  • Earning Date
  • EXAS 07-30-2025
  • HII 07-31-2025
  • Dividend Yield
  • EXAS N/A
  • HII 2.45%
  • EPS Growth
  • EXAS N/A
  • HII N/A
  • EPS
  • EXAS N/A
  • HII 13.88
  • Revenue
  • EXAS $2,828,128,000.00
  • HII $11,464,000,000.00
  • Revenue This Year
  • EXAS $14.58
  • HII $4.21
  • Revenue Next Year
  • EXAS $12.75
  • HII $4.47
  • P/E Ratio
  • EXAS N/A
  • HII $16.08
  • Revenue Growth
  • EXAS 11.57
  • HII N/A
  • 52 Week Low
  • EXAS $39.97
  • HII $158.88
  • 52 Week High
  • EXAS $72.83
  • HII $285.81
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 60.75
  • HII 48.55
  • Support Level
  • EXAS $55.26
  • HII $219.82
  • Resistance Level
  • EXAS $58.68
  • HII $229.24
  • Average True Range (ATR)
  • EXAS 1.99
  • HII 4.24
  • MACD
  • EXAS -0.27
  • HII -1.45
  • Stochastic Oscillator
  • EXAS 62.66
  • HII 25.48

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out of Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia and Columbia-class nuclear submarines. Huntington Ingalls shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's Mission Technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: